目录
更新日期:2025年11月17日
姓 名 肖晓 性 别
民 族 汉族 导师层次 硕士导师
技术职称 副研究员 导师类型 学术&专业型
最后学历 博士研究生毕业 最后学位 理学博士学位
行政职务 其他 Email xiaoxiao@gdph.org.cn
工作单位 广东省人民医院 邮政编码
个人简介

本人长期以来致力于药物筛选和溶瘤病毒研究;作为核心成员参与完成了新药溶瘤病毒M1的研究工作,相关成果发表在PNASNCSci. Transl. MedCell reports等杂志。目前本人参与发表13SCI文章(第一作者3篇),3篇中文核心期刊(第一作者),主持多项国家级、省、市级科研项目。作为合作发明人获得国家发明专利6

研究领域

抗肿瘤药物,微生物药物研发

个人成果

(1)Xiao Xiao#; Yingying Shen#; Liyang Yin; Jun He; Xiaoyu Ni; Gang Luo; Xiguang Chen; Wenbo Zhu; Jing Zhong; Jianghua Liu; Xiuda Peng; Xuyu Zu, Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha, Life sciences, 2019, 239: 117042

(2) Chunlong Huang*; Weihua Lai*; Shuai Mao; Deli Song; Jihong Zhang#; Xiao Xiao#; Quercetin-induced degradation of RhoC suppresses hepatocellular carcinoma invasion and metastasis. Cancer Medicine. 2024

(3) Jiankai Liang#; Li Guo#; Kai Li; Xiao Xiao; Wenbo Zhu; Xiaoke Zheng; Jun Hu; Haipeng Zhang; Jing Cai; Yaya Yu; Yaqian Tan; Chuntao Li; Xincheng Liu; Cheng Hu; Ying Liu; Pengxin Qiu; Xingwen Su; Songmin He; Yuan Lin*; Guangmei Yan*, Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus, Nature Communications, 2018, 9(1): 1524

(4) Chengyang Lai# , Yangchen Li#, Wenwei Luo, Bin Zhang , Chen Liu , Liming Peng , Hanping Li , Ju-e Liu* , Xiao Xiao*, Shilong Zhong*. Plasma Metabolomics Differentiating and Predicting Prognosis of Coronary Artery Disease Patients with Distinct Nutritional Status, Nutrition Research, 2025

(5) Gongjie Guo#; Yonglin Wu#; Yingjian Liu1#; Zixian Wang; Guifeng Xu; Xipei Wang; Feiqing Liang; Weihua Lai; Xiao Xiao*; Qian Zhu* and Shilong Zhong*, Exploring the Causal Effects of the Gut Microbiome on Serum Lipid Levels: A Two-sample Mendelian Randomization Analysis Front. Microbiol., 2023, 14